Comparison

UK-78282 hydrochloride European Partner

Item no. ALO-U-100-25mg
Manufacturer Alomone
CASRN 136647-02-4
Amount 25 mg
Quantity options 10 mg 25 mg 50 mg 5 mg
Category
Type Small Molecules
Format Lyophilized
Specific against other
Purity >95%
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Room temperature
Available
Manufacturer - Type
Non Antibodies
Manufacturer - Category
S. Molecules
Manufacturer - Targets
KV1.3, KV1.4 K+ channels
Country of Origin
Israel
Shipping Temperature
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
Storage Conditions
Storage as Solution: Up to four weeks at 4°C or three months at -20°C.
Molecular Weight
466, 1
Manufacturer - Format
Lyophilized Powder
Short description
A Blocker of KV1.3 and KV1.4 K+ Channels
Description
A Blocker of KV1.3 and KV1.4 K+ Channels
Reconstitution
200 mM in DMSO. Centrifuge all product preparations before use (10000 x g for 1 min).
PH
7, 4
UNSPSC
41116134
Effective Concentration
200 nM - 200 µM.
Activity
UK-78282 hydrochloride blocks KV1.3 and KV1.4 in T lymphocytes1.
Solubility
200 mM in DMSO. Centrifuge all product preparations before use (10000 x g for 1 min).
Bioassay tested
Yes
Chemical Name
4-(benzhydryloxymethyl)-1-[3-(4-methoxyphenyl)propyl]piperidine; hydrochloride.
Scientific Background
UK-78282 hydrochloride is a novel piperidine blocker of the T lymphocyte voltage-gated K+ channel, KV1.3 and KV1.4 with IC50 values of 0.28 and 0.17 μM respectively. UK-78282 suppresses T lymphocyte mitogenesis and leads to membrane depolarization. UK-78282 also blocks KV1.4 expressed in heart and brain. UK-78282 preferentially blocks the C-type inactivated state of the KV1.3 channel. KV1.3 mutants containing hydrophobic residues that might prefer to be buried, transition slowly into the C-type inactivated conformation and are insensitive to block by UK-78282, possibly because of the inability of the drug to bind the channel. UK-78282 hydrochloride serves as an experimental tool to probe the conformational changes in KV1.3 leading to C-type inactivation and to further define the critical physiological role of KV1.3 in T lymphocyte activation1.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Delivery expected until 12/4/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close